120 likes | 206 Views
Explore historic examples of unsafe or misleading pharmaceutical marketing practices and their impact on the industry. Analyze case studies and FDA warnings to understand past mistakes and prevent future issues. Beneficial for pharmaceutical professionals and consumers alike.
E N D
vti_cachedlinkinfo:VX|H|http://www.eyeonfda.com/eye_on_fda/pdufa/index.html H|http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=382534 H|http://www.fda.gov/cder/ddmac/organizationlist.htm H|http://www.fda.gov/cder/handbook/ddmacrev.htm H|http://www.fda.gov/cder/warn/2006/nevanac-wl.pdf H|http://www.fda.gov/cder/warn/2006/nevanac-promo.pdf H|http://www.fda.gov/cder/warn/2006/Dyrenium-promo.pdf H|http://www.fda.gov/cder/warn/2006/Dyrenium-letter.pdf H|http://www.fda.gov/cder/warn/2006/Gatroview-Optimark-promo.pdf H|http://www.fda.gov/cder/warn/2006/Gastroview-wl.pdf
vti_cachedsvcrellinks:VX|NHHS|http://www.eyeonfda.com/eye_on_fda/pdufa/index.html NHHS|http://www.pharmexec.com/pharmexec/article/articleDetail.jsp NHHS|http://www.fda.gov/cder/ddmac/organizationlist.htm NHHS|http://www.fda.gov/cder/handbook/ddmacrev.htm NHHS|http://www.fda.gov/cder/warn/2006/nevanac-wl.pdf NHHS|http://www.fda.gov/cder/warn/2006/nevanac-promo.pdf NHHS|http://www.fda.gov/cder/warn/2006/Dyrenium-promo.pdf NHHS|http://www.fda.gov/cder/warn/2006/Dyrenium-letter.pdf NHHS|http://www.fda.gov/cder/warn/2006/Gatroview-Optimark-promo.pdf NHHS|http://www.fda.gov/cder/warn/2006/Gastroview-wl.pdf
vti_cachedtitle:SR|Historic Examples of Unsafe or Misleading Pharmaceutical Marketing
vti_title:SR|Historic Examples of Unsafe or Misleading Pharmaceutical Marketing